Daily trading volumes for Aldeyra Therapeutics (NASDAQ: ALDX) fluctuate dynamically based on clinical trial updates, regulatory announcements from the FDA, and broader biotechnology sector sentiment. On typical trading days, share turnover ranges across hundreds of thousands of shares, spiking significantly during major corporate disclosures or earnings releases.